Perioperative anaesthetic management of patients undergoing thoracic cytoreductive surgery and HITHOC.

ABSTRACT: Historically, patients with pleural malignant mesothelioma have had a poor prognosis and survival rate. Recently, new surgical approaches and chemotherapy delivery techniques have been developed. One of this treatment options is thoracic cytoreductive surgery and HITHOC (hyperthermic intrathoracic chemotherapy perfusion), a promising strategy in selected patients, offering significantly longer median survival length and tumour-free survival rate. However, there is little experience and little is known regarding the optimal perioperative management of this patients. Given that they usually present with poor preoperative status and the surgery is aggressive, prolonged and associated with significant hemodynamic repercussions, this procedure poses a true challenge to the anaesthesiologist. We

SUBMITTER: Unigarro-Londono F 

PROVIDER: S-EPMC8263865 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature